Transcription factor involved in the specification of the lactotrope, somatotrope, and thyrotrope phenotypes in the developing anterior pituitary. Activates growth hormone and prolactin genes. Specifically binds to the consensus sequence 5'- TAAAT-3'. Belongs to the POU transcription factor family. Class- 1 subfamily. 2 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Biological Process: transcription from RNA polymerase II promoter; negative regulation of cell proliferation; nuclear transport; regulation of insulin-like growth factor receptor signaling pathway; regulation of transcription, DNA-dependent; positive regulation of transcription, DNA-dependent; B cell differentiation; positive regulation of cell proliferation; somatotropin secreting cell development; positive regulation of inositol trisphosphate biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; cell fate specification; negative regulation of transcription from RNA polymerase II promoter; determination of adult life span; positive regulation of multicellular organism growth
LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.